FDA Fast-Tracks First Nasal Spray for Allergic Reactions, Anaphylaxis

The US Food and Drug Administration (FDA) recently approved neffy, an epinephrine nasal spray, to treat emergency allergic reactions, including anaphylaxis. The spray is the first alternative treatment to epinephrine injections for adults and children who weigh at least 30 kg, or about 66 lb.